Home › Degenerative Nerve Diseases › Massachusetts › Boston
Degenerative Nerve Diseases clinical trials in Boston, MA
5 studies for Degenerative Nerve Diseases are looking for participants at sites in and around Boston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
RecruitingPhase 2
- Massachusetts General Hospital - Charlestown, Charlestown · 1 mi away
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
RecruitingPhase 1
- Massachusetts General Hospital (MGH), Charlestown · 1 mi away
An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease
RecruitingPhase 1/2
- Massachusetts General Hospital /ID# 270960, Boston
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
RecruitingObservational studyHealthy volunteers welcome
- Boston University, Boston
- Massachusetts General Hospital, Boston
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq)
RecruitingObservational study
- Boston Children's Hospital, Boston
About Degenerative Nerve Diseases
Degenerative nerve diseases, or neurodegenerative diseases, are disorders that destroy cells in your nervous system. Learn about the types and treatments.
More about Degenerative Nerve Diseases on MedlinePlus
Degenerative Nerve Diseases trials in other cities
- Philadelphia, PA6 studies
- Orlando, FL5 studies
- Tampa, FL5 studies
- Scottsdale, AZ4 studies
- San Diego, CA4 studies
- Atlanta, GA4 studies
- Baltimore, MD3 studies
- Los Angeles, CA3 studies
- Farmington Hills, MI3 studies
- Austin, TX3 studies
- West Palm Beach, FL3 studies
- Miami, FL3 studies
Other studies in Boston
- Breast Cancer110 studies
- Cancer (all types)90 studies
- Non-Small Cell Lung Cancer87 studies
- Lung Cancer63 studies
- Colorectal Cancer62 studies
- Ovarian Cancer62 studies
- Metastatic Cancer61 studies
- Prostate Cancer56 studies
- Endometrial Cancer51 studies
- Depression50 studies
- Heart Failure46 studies
- Multiple Myeloma45 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.